Although conceived initially as a drug target for the control of lipid metabolism, HCAR2 therefore has potential as a route to novel treatments of a wide range of inflammatory diseases, as well as atherosclerosis, multiple sclerosis and Parkinson’s disease, and as a result it is of growing interest for pharmaceutical applications. This evidence concerns the gene HCAR2 and multiple sclerosis.